Smith CD, Cyr M.The history of lupus erythematosus from Hipprocates to Osler. Rheum Dis Clin N America1988; 14: 1-14.
2.
Willan R.On Cutaneous Diseases. Vol 1. Johnson J: London, 1808
3.
Bateman T.A Practical synopsis of cutaneous diseases according to the arrangement of Dr Willan. Longman Hurst Rees Orme and Brown: London, 1813.
4.
Hebra F.On Diseases of the Skin including the Exanthemata. Vol 1. The New Sydenham Society: London , 1866. Pp 114-118. (Transl. By CH Fagge).
5.
Kaposi M.Lupus erythematosus. In: Hebra H, Kaposi M (eds). Diseases of the Skin including the Exanthemata. Vol IV. 1875, The New Sydenham Society: London, 1880, 14-37. (transl. By W Tay).
6.
Casenave Pla, Schedel HEAbrégé Pratique des Maldies de la Peau. 2nd Ed. Bechet: Paris, 1833 .
7.
Cazenave Pla, Schedel HEManual of Diseases of the Skin. Henry Renshaw: London, 1852. (transl. by Burgess).
8.
Hebra F.Bericht uber die leistungen in der dermatologie. Jahresbericht uber die fortschritte der gesamten medicin in allen landem im Jahre 1845. Herausgegeben von Dr Canstatt unt Dr Eisemann. Vol 1. Ferdinand Enke: Erlangen, 1846, 226-227.
9.
Casenave Pla.Lupus erythemateux (erytheme centrifuge). Annales des maladies de la peau et de la syphilis1850- 1851; 3: 297-299.
10.
Hutchinson J.Lupus erythematosus. Med Times Gaz1879; 1: 1-3.
11.
Hutchinson J.On lupus and its treatment. Brit Med J1880; 1: 650-652.
12.
Crocker HRTreatise on Diseases of the Skin, their Description, Diagnosis and Treatment P Blakiston & Co: Philadelphia, 1888.
13.
14.
Kaposi M.Nene Beitrage zur Kenntniss des Lupus Erythematosus. Arch Dermatol Syph1872; 4: 36-78.
Gilliam JNThe cutaneous signs of lupus erythematosus. Continuing education for the family physician1977; 6: 34-40.
20.
Rowell NRThe natural history of lupus erythematosus. Clin Exper Dermatol1984; 9: 217-231.
21.
Osler W.On the visceral complications of erythema exudativum multiforme. Am J Med Sci1895; 110: 629-646.
22.
Sequeira JH , Balean H.Lupus erythematosus: a clinical study of seventy-one cases. Br J Dermatol1902 ; 14: 367-379.
23.
Jadassohn J.Lupus erythematodes In: Mracek F (ed). Handbuck der Hantbrank Leiten. Alfred Holder : Wien, 1904, 298-404
24.
Libman E., Sacks B.A hitherto undescribed form of valvular and mural endocarditis. Arch Int Med1924; 33: 701-737.
25.
Baehr G., Klemperer P., Schifrin A.Diffuse disease of the peripheral circulation usually associated with lupus erythematosus and endocarditis. Trans Assoc Am Phys1935; 50: 139-155.
26.
Klemperer P. , Pollack AD, Baehr G.Diffuse collagen disease: acute disseminated lupus erythematosus and diffuse scleroderma. JAMA1942; 119: 331-332.
27.
Harvey A McG et al. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine1954; 33: 291-437.
28.
Keil H.Conception of lupus erythematosus and its morphological variants with particular reference to 'systemic' lupus erythematosus. Arch Derm Syph1937; 36: 729-757.
29.
Rothfield NFChronic lupus erythematosus. A study of 65 patients and 65 controls. N Engl J Med1963; 269: 1155-1161.
30.
Millard LG, Rowell NRAbnormal laboratory tests results and their relationship to prognosis in discoid lupus erythematosus. Arch Dermatol1979 ; 115: 1055-1058.
31.
Beck JS, Rowell NRDiscoid lupus erythematosus. A study of the clinical features and biochemical and serological abnormalities in 120 patients with observations on the relationship of this disease to systemic lupus erythematosus. Quart J Med1966; 35: 119-136. 32 Millard LG, Rowell NR, Rajah SMHistocompatibility antigens in discoid and systemic lupus erythematosus. Brit J Dermatol1977; 96: 139-144.
32.
Sontheimer RD, Thomas JR, Gilliam JNSubacute cutaneous lupus erythematosus-a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol1979; 115: 1409-1415.
33.
Hauck L.The positive reaction of the Wassermann-Neisser-Bruck test in acute lupus erythematosus. Munchen Med Wschr1910; 57: 17.
34.
Haserick JR , Long R.Systemic lupus erythematosus preceded by false-positive serological tests for syphilis: presentation of five cases. Ann Int Med1952; 37: 559-565.
35.
Hargraves MMDiscovery of the LE cell and its morphology . Mayo Clin Proc1969; 44: 579-599.
36.
Hargraves MM , Richmond H., Morton R.Presentation of 2 bone marrow elements: 'tart' cell and 'L.E.' cell. Proc Staff Meet Mayo Clin1948; 23: 25-28.
37.
Haserick JR , Lewis LA, Bortz DWBlood factor in acute disseminated lupus erythematosus: determination of gamma globulin as specific plasma fraction. Am J Med Sci1950; 219: 660-663.
38.
Beck JSVariations in the morphological patterns of autoimmune fluorescence. Lancet1961; 1: 1203-1205.
39.
Anderson JR et al. Precipitating autoantibodies in the connective tissue diseases. Ann Rheum Dis1962; 21: 360-369.
40.
Clark G., Reichlin M., Tomasi TBCharacterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol1969; 102: 117-120.
41.
Mattioli M. , Reichlin M.Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen. Arthritis Rheum1974; 17: 421-429.
Esscher E., Scott JSCongenital heart block and maternal lupus erythematosus. Br Med J1979; 1: 1235-1238.
44.
Tan EM, Kunkel HGCharacteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol1966; 96: 464-471.
45.
Mattioli M. , Reichlin M.Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera. J Immunol1971; 107: 1281-1290.
46.
Sharp GC et al. Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med1972; 52: 148-159.
47.
Rowell NR, Beck JS, Anderson JRLupus erythematosus and erythema multiforme-like lesions. Arch Dermatol1963 ; 88: 176-180.
48.
Hughes GRThrombosis, abortion, cerebral disease and the lupus anticoagulant. Br Med J1983; 287: 1088-1089.
49.
Hughes GR, Mackworth-Young C., Harris EN, Gharavi AEVenoocclusive disease in systemic lupus erythematosus: possible association with anti-cardiolipin antibodies?. Arthritis Rheum1984; 27: 1071.
50.
Goeckerman WH, Montgomery H.Lupus erythematosus: an evaluation of histopathologic examination. Arch Derma & Syph132; 25: 304.
51.
McCreight WG , Montgomery H.Cutaneous changes in lupus erythematosus: histopathologic aspects with special reference to vascular changes. Arch Dermatol & Syph1950; 61: 1.
52.
Burnham TK, Neblett TR, Fine G.Application of fluorescent antibody technic to the investigation of lupus erythematosus and various dermatoses. J Invest Dennatol1963; 41: 451-456.
53.
Cormane RHBand globulin in the skin of patients with chronic discoid lupus erythematosus and systemic lupus erythematosus. Lancet1964 ; 1: 534-535.
54.
Keil H.Relationship between lupus erythematosus and tuberculosis: critical review based on observations at necropsy. Arch Dermatol1933; 28: 765-779.
55.
Gold S.Role of sulphonamides and penicillin in the pathogenesis of systemic lupus erythematosus. Lancet1951; 1: 268-272.
56.
Morrow JD, Schroeder HA, Perry HM Jr. Studies on the control of hypertension by Hyphex II. Toxic reactions and side effects. Circulation1953; 8: 829-839.
57.
Ladd ATProcaincamide-induced lupus erythematosus. N Engl J Med1962; 267: 1357-1389.
58.
Burnet FMThe Clonal Selection Theory of Acquired Immunity. Vanderbilt University Press:Nashville, Tennessee, 1959.
Burch Prj, Rowell NRLupus erythematosus. Analysis of the sex and age—distributions of the discoid and systemic forms of the disease in different countries . Acta Derm Venereol1970; 40: 293-301.
Davidson AM, Birt ARQuinine bisulphate as a densitizing agent in the treatment of lupus erythematosus . Arch Derrnat and Syph1938; 37: 247-253.
63.
Page F.Treatment of lupus erythematosus with mepacrine. Lancet1951; 2: 755-758.
64.
Prokopchuk A/IA.Lechenie eritematoznoi volchanki akrikhinom . Vestnik venerol i dermat1940; 2-3: 23-26. Translation in English by Zakon SJ, Gershenson J Arch Derm Syph195571520-521.
65.
Dalziel K. et al. Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin). Brit J Dermatol1986; 115: 211-216.
66.
Hench PS, Kendall EC, Slocumb CH, Folley HFEffect of hormone of adrenal cortex (17-Hydroxy-11-Dehydrocortisone: Compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis; preliminary report. Proc Mayo Clin1949; 24: 181-197.
67.
Osbome ED, Jordan JW, Hoak FC, Pschierer FJNitrogen mustard therapy in cutaneous blastomatous disease. JAmer Med Ass1947; 135: 1123-1128.
68.
Talbott JHHistorical background of discoid and systemic lupus erythematosus in Duboi's Lupus Erythematosus. 4th edn. Wallace DJ, Hahn BH (eds). Lea and Febiger: 3-10, 1993.